IBDEI10T ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16412,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16412,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16412,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16413,0)
 ;;=I38.^^88^878^4
 ;;^UTILITY(U,$J,358.3,16413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16413,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,16413,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,16413,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,16414,0)
 ;;=I05.0^^88^878^18
 ;;^UTILITY(U,$J,358.3,16414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16414,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,16414,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,16414,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,16415,0)
 ;;=I05.8^^88^878^19
 ;;^UTILITY(U,$J,358.3,16415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16415,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,16415,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,16415,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,16416,0)
 ;;=I05.9^^88^878^20
 ;;^UTILITY(U,$J,358.3,16416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16416,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16416,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,16416,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,16417,0)
 ;;=I07.1^^88^878^21
 ;;^UTILITY(U,$J,358.3,16417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16417,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,16417,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,16417,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,16418,0)
 ;;=I07.9^^88^878^22
 ;;^UTILITY(U,$J,358.3,16418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16418,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16418,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,16418,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,16419,0)
 ;;=I08.0^^88^878^16
 ;;^UTILITY(U,$J,358.3,16419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16419,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,16419,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,16419,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,16420,0)
 ;;=I09.89^^88^878^17
 ;;^UTILITY(U,$J,358.3,16420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16420,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,16420,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,16420,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,16421,0)
 ;;=I47.1^^88^878^24
 ;;^UTILITY(U,$J,358.3,16421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16421,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,16421,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,16421,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,16422,0)
 ;;=I48.0^^88^878^15
 ;;^UTILITY(U,$J,358.3,16422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16422,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,16422,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,16422,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,16423,0)
 ;;=I49.5^^88^878^23
 ;;^UTILITY(U,$J,358.3,16423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16423,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,16423,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,16423,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,16424,0)
 ;;=I49.8^^88^878^3
 ;;^UTILITY(U,$J,358.3,16424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16424,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,16424,1,4,0)
 ;;=4^I49.8
